Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 28, 2011
Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Court of Appeals for the Federal Circuit found in favor of the Company in a...
-
Sep 19, 2011Ultra-low profile, highly deliverable balloon dilatation catheter offers physicians exceptional performance in peripheral angioplasty procedures
Boston Scientific Corporation (NYSE: BSX) has launched its Coyote™ Balloon Catheter, a highly deliverable and ultra-low profile 0.014 inch balloon...
-
Sep 15, 2011Company supports women's health through online community launched by American Urogynecologic Society (AUGS) at annual meeting
Boston Scientific Corporation (NYSE: BSX) is further supporting the advancement of women's health as the founding sponsor of the American...
-
Sep 13, 2011Mahoney Has Served as Worldwide Chairman, Medical Device and Diagnostics Group, Johnson & Johnson
Attracting one of med-tech's most inspiring leaders, Boston Scientific Corporation (NYSE: BSX) has named Michael Mahoney, 46, as President of the...
-
Sep 9, 2011
Boston Scientific Corporation (NYSE: BSX) today issued the following statement from John Pedersen, Senior Vice President and President of the Company's...
-
Sep 2, 2011
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Morgan Stanley Global Healthcare Conference on September 14 in New York....
-
Sep 2, 2011
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Morgan Stanley Global Healthcare Conference on September 14 in New York....
-
Aug 10, 2011Company also introduces industry's first iPhone®/iPad® app for healthcare professionals using SCS
Boston Scientific Corporation (NYSE: BSX) has launched its Neuromodulation Learning Institute™ (NLI), a clinical education program and online...
-
Aug 9, 2011Company's fully covered metal stent now approved in Canada for use in treating benign biliary strictures
Natick, MA (August 9, 2011) – Boston Scientific Corporation’s (NYSE: BSX) WallFlex® Biliary RX Fully Covered Stent has received Health Canada approval for the treatment of benign biliary...
-
Aug 8, 2011
Boston Scientific Corporation (NYSE: BSX) today announces the U.S. Court of Appeals for the First Circuit has affirmed the dismissal of a...